Nasdaq: SLS

SELLAS Life Sciences Group, Inc. (SLS)

SELLAS Life Sciences Group, Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker SLS. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
SLS
Exchange
Nasdaq
SEC CIK
1390478
Official filings
SEC EDGAR

Research SLS

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is SELLAS Life Sciences Group, Inc.'s stock ticker?

SELLAS Life Sciences Group, Inc. trades under the ticker symbol SLS on Nasdaq. Its SEC Central Index Key (CIK) is 1390478.

Where can I read SELLAS Life Sciences Group, Inc.'s SEC filings?

The SLS SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports SELLAS Life Sciences Group, Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze SLS's financial statements?

The SLS Financials page shows SELLAS Life Sciences Group, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does SLS compare with its peers and the market?

The SLS Peer Comparison page lines SELLAS Life Sciences Group, Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.